NCT07070232: A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 1,438 planned
- Started
- 12 Aug 2025
- Primary completion
- Mar 2028
- Arms
- Part 1 (Cohort 1A) - BNT326 monotherapy, Part 1 (Cohort 1B) - BNT326 monotherapy, Part 1 (Cohort 1C) - BNT326 monotherapy, Part 1 (Cohort 1D) - BNT326 monotherapy, Part 1 (Cohort 1E) - BNT326 monotherapy, Part 1 (Cohort 1G) - BNT326 monotherapy, Part 2 (Cohort 2D1) - BNT326 monotherapy, Part 2 (Cohort 2E1) - BNT326 monotherapy
- Results
- None posted
- 17 Jul 2025: Trial registered
- 12 Aug 2025: Trial started